Our strong in-house development team combines the expertise of clinical, regulatory, pharmacovigilance, medical affairs, scientific publications functions with a ‘virtual’ network model for pre-clinical development. Our Development Centre is located in Hengoed, Wales.
GELSECTAN is a trademark licensed by Noventure S.L. to the Norgine group of companies..
XIFAXAN, XIFAXANTA, TARGAXAN and TIXTAR are registered trademarks of the Alfa Wassermann group of companies, licensed to the Norgine group of companies.